NCT04283539 2023-11-13Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer ImmunotherapyNational Jewish HealthUnknown238 enrolled
NCT03383952 2017-12-27A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaImmune Cell, Inc.Phase 1 Unknown20 enrolled
NCT03383965 2017-12-27CD30 Targeted CAR-T in Treating CD30-Expressing LymphomasImmune Cell, Inc.Phase 1 Unknown20 enrolled